Mehdi Touat - Concepedia

Author

Mehdi Touat

Also Known As

Emeline Tabouret, Jan C Buckner, M TOUAT, M Touat, M. Touat, Mehdi Touat, Mehdi, Touat, Stephanie Bombois, Stéphanie Bombois, Touat, Mehdi

275

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Assistance Publique – Hôpitaux de Paris Inserm Institut du Cerveau Centre National de la Recherche Scientifique

About

Mehdi Touat is an author at Sorbonne Université specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.6K
2	Health Sciences	3	3	142
3	Engineering	1	1	45
4	Natural Sciences	1	1	28
5	Public Health	1	1	18

Mehdi Touat

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Mechanisms and therapeutic implications of hypermutation in gliomas Mehdi Touat, Yvonne Y. Li, Adam N. Boynton, Nature Neuro-oncologyMedicineTherapeutic ImplicationsHigh-grade GliomasCell Biology	2020	661
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, New England Journal of Medicine	2023	606
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer Mehdi Touat, Thierry Maisonobe, Omar Ben Hadj Salem, Neurology	2018	324
BRAF Inhibition in <i>BRAF</i><sup>V600</sup>-Mutant Gliomas: Results From the VE-BASKET Study Thomas Kaley, Mehdi Touat, Vivek Subbiah, Journal of Clinical Oncology	2018	317
Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Journal of Clinical Oncology	2020	285
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma Anna Luisa Di Stefano, Alessandra Fucci, Veroniquè Frattini, Clinical Cancer Research Oncologic ImagingIdh Wild-type GliomaPathologyImmunotherapeuticsHigh-grade Gliomas	2015	266
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma Rimas V. Lukas, Jordi Rodón, Kevin Becker, Journal of Neuro-Oncology Neuro-oncologyOncologyMedicinePathologyAnti-cancer Agent	2018	146
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial Patrick Y. Wen, Mehdi Touat, Brian M. Alexander, Journal of Clinical Oncology	2019	146
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection David Capper, Guido Reifenberger, Pim J. French, Neuro-Oncology Recurrent GliomasHigh-grade GliomasBrain LesionGliomaTumor Biology	2023	93
<i>FGFR1</i> actionable mutations, molecular specificities, and outcome of adult midline gliomas Alberto Pïcca, Giulia Berzero, Franck Bielle, Neurology	2018	85

Page 1